27 Ray Dalio United Therapeutics Trades
Ray Dalio acquired 194 Thousand United Therapeutics shares worth $55.1 Million. That's 0.24% of their equity portfolio (81st largest holding). The first United Therapeutics trade was made in Q4 2015. Since then Ray Dalio bought shares fifteen more times and sold shares on eleven occasions. The investor's estimated purchase price is $60 Million, resulting in a loss of 8.2%.
Avg closing price
Price range
Increased shares by 79.9% (+86.1 Thousand shares)
Q1 2025
Avg closing price
$343.78
Price range
$304.42
-
$380.78
Increased shares by 74.4% (+46 Thousand shares)
Q4 2024
Avg closing price
$367.42
Price range
$348.65
-
$410.00
Increased shares by 384.3% (+49 Thousand shares)
Q3 2024
Avg closing price
$337.78
Price range
$311.04
-
$363.55
Increased shares by 60.4% (+4.8 Thousand shares)
Q2 2024
Avg closing price
$264.67
Price range
$228.26
-
$319.04
Sold 11.9% shares (-1.07 Thousand shares)
Q1 2024
Avg closing price
$225.66
Price range
$210.76
-
$249.51
Sold 50.3% shares (-9.13 Thousand shares)
Q4 2023
Avg closing price
$230.49
Price range
$214.88
-
$256.94
Sold 55.5% shares (-22.7 Thousand shares)
Q3 2023
Avg closing price
$230.33
Price range
$211.82
-
$248.24
Sold 1.1% shares (-460 shares)
Q2 2023
Avg closing price
$221.50
Price range
$205.19
-
$232.99
Increased shares by 64.4% (+16.2 Thousand shares)
Q1 2023
Avg closing price
$246.53
Price range
$212.99
-
$276.17
Sold 43.2% shares (-19.1 Thousand shares)
Q4 2022
Avg closing price
$252.44
Price range
$205.95
-
$280.43
Sold 18.8% shares (-10.2 Thousand shares)
Q3 2022
Avg closing price
$223.56
Price range
$203.30
-
$244.17
New holding (+54.4 Thousand shares)
Q2 2022
Avg closing price
$203.30
Price range
$174.81
-
$241.14
Sold -9.12 Thousand shares
Q2 2019
Avg closing price
$93.51
Price range
$76.06
-
$120.81
New holding (+9.12 Thousand shares)
Q1 2019
Avg closing price
$116.52
Price range
$107.15
-
$126.84
Sold -53.7 Thousand shares
Q4 2018
Avg closing price
$115.95
Price range
$101.40
-
$128.73
Increased shares by 18.5% (+8.4 Thousand shares)
Q3 2018
Avg closing price
$123.69
Price range
$113.81
-
$129.46
Sold 71.9% shares (-116 Thousand shares)
Q2 2018
Avg closing price
$109.92
Price range
$101.14
-
$118.31
Increased shares by 72.2% (+67.6 Thousand shares)
Q1 2018
Avg closing price
$127.04
Price range
$107.21
-
$151.94
Increased shares by 1.0% (+953 shares)
Q4 2017
Avg closing price
$127.12
Price range
$118.58
-
$151.28
Increased shares by 25.4% (+18.8 Thousand shares)
Q3 2017
Avg closing price
$127.70
Price range
$114.60
-
$136.81
